Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 850 of 1,261
  1. US 8545813

    Pre-templated macromolecular architectures with multiple Gd(III) complexes and methods of use as MRI contrast agents

    Northwestern University · Granted Oct 1, 2013 · Expires Sep 26, 2033

    granted
  2. US 8545847

    Human antibodies to the human glucagon receptor and methods of use thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 1, 2013 · Expires Sep 26, 2033

    granted
  3. US 8545927

    Lactoferrin-based biomaterials for tissue regeneration and drug delivery

    UNIVERSITY OF CONNECTICUT · Granted Oct 1, 2013 · Expires Sep 26, 2033

    granted
  4. US 8546091

    AKT phosphorylation at Ser473 as an indicator for taxane-based chemotherapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 1, 2013 · Expires Sep 26, 2033

    granted
  5. US 8546414

    Ion channel modulators and methods of use

    Vertex Pharmaceuticals Incorporated · Granted Oct 1, 2013 · Expires Sep 26, 2033

    granted
  6. US 8546493

    Multi-armed, monofunctional, and hydrolytically stable derivatives of poly(ethylene glycol) and related polymers for modification of surfaces and molecules

    Nektar Therapeutics · Granted Oct 1, 2013 · Expires Sep 26, 2033

    granted
  7. US 8546398

    Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Oct 1, 2013 · Expires Sep 26, 2033

    granted
  8. US 8546376

    Pharmaceutical compounds

    ALMAC DISCOVERY LIMITED · Granted Oct 1, 2013 · Expires Sep 26, 2033

    granted
  9. US 8546143

    Compositions and methods for inhibiting expression of a target gene

    Alnylam Pharmaceuticals, Inc. · Granted Oct 1, 2013 · Expires Sep 26, 2033

    granted
  10. US 8546331

    Modulation of pathogenic CD14+/CD16+ monocytes

    XBIOTECH INC. · Granted Oct 1, 2013 · Expires Sep 26, 2033

    granted
  11. US 8546322

    Inhibitors of intracellular urokinase plasminogen activator and methods of use thereof

    The Regents of the University of California · Granted Oct 1, 2013 · Expires Sep 26, 2033

    granted
  12. US 8545885

    Stable laquinimod preparations

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 1, 2013 · Expires Sep 26, 2033

    granted
  13. US 8546348

    Upregulation of opioid receptors for management

    The Board of Regents of the University of Texas System · Granted Oct 1, 2013 · Expires Sep 26, 2033

    granted
  14. US 8546371

    Nanoparticle formulated glycolipid antigens for immunotherapy

    The Board of Regents of the University of Texas System · Granted Oct 1, 2013 · Expires Sep 26, 2033

    granted
  15. US 8546433

    Axl inhibitors for use in combination therapy for preventing, treating or managing metastatic cancer

    Rigel Pharmaceuticals, Inc. · Granted Oct 1, 2013 · Expires Sep 26, 2033

    granted
  16. US 8548557

    Medical electrodes

    Covidien LP · Granted Oct 1, 2013 · Expires Sep 26, 2033

    granted
  17. US 8546612

    Phenyl-N-acyl derivatives of amines and amino acids, a process for the preparation thereof, a pharmaceutical composition and use thereof

    OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES” · Granted Oct 1, 2013 · Expires Sep 26, 2033

    granted
  18. US 8546554

    Lipid formulated compositions and methods for inhibiting expression of Serum Amyloid A gene

    Alnylam Pharmaceuticals, Inc. · Granted Oct 1, 2013 · Expires Sep 26, 2033

    granted
  19. US 8546524

    Smoothened polypeptides and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 1, 2013 · Expires Sep 26, 2033

    granted
  20. US 8541221

    Primate T-lymphotropic viruses

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Sep 24, 2013 · Expires Sep 19, 2033

    granted
  21. US 8541024

    Film-coated scored tablet

    Takeda Pharmaceutical Company Limited · Granted Sep 24, 2013 · Expires Sep 19, 2033

    granted
  22. US 8541375

    Glycopeptide phosphonate derivatives

    Theravance, Inc. · Granted Sep 24, 2013 · Expires Sep 19, 2033

    granted
  23. US 8541373

    BChE albumin fusions for the treatment of cocaine abuse

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Sep 24, 2013 · Expires Sep 19, 2033

    granted
  24. US 8541185

    Method of predicting responsiveness to autologous adoptive cell transfer therapy

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Sep 24, 2013 · Expires Sep 19, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.